课题基金 / 基金详情

TOTAL SYNTHESES OF BIOACTIVE MOLECULES VIA VINYL SULFONE

TOTAL SYNTHESES OF BIOACTIVE MOLECULES VIA VINYL SULFONE
通过乙烯基砜全合成生物活性分子
批准号:
2684767
负责人:
PHILIP L FUCHS
金额:
$19.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-12-01 至 1999-03-31

项目摘要

项目成果

PHILIP L FUCHS的其他基金

相似基金

相关文献

中文摘要
翻译
本提案寻求合成天然的对映体
英文摘要
This proposal seeks to synthesize the natural enantiomers of the biologically significant natural products (1) Roseophilin; (2) Pancratistatin; and (3) Ibogaine. A fourth goal is the development of a new annulation procedure for synthesis of halogenated indoles. The overall program seeks to expand the scope of vinyl sulfone chemistry for the synthesis of the above natural products. An additional unifying feature is the investigation of azoene and transition metal chemistry to achieve the construction and/or delivery of the pyrrole and indole portions of the targeted alkaloids.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
The intramolecular migration of a trimethylsilyl group located alpha to a sulfone in substituted cyclohexyl systems.
在取代的环己基体系中,三甲基甲硅烷基在砜的α位进行分子内迁移。
DOI: 10.1002/rcm.1290040102
发表时间: 1990
期刊: Rapid communications in mass spectrometry : RCM
影响因子: --
作者: [Wood,KV, Rothwell,AP, Anderson,MB, Fuchs,PL]
通讯作者: Fuchs,PL
Asymmetric epoxy cyclohexenyl sulfones: readily accessible progenitors of stereo defined six-carbon arrays.
不对称环氧环己烯基砜:立体定义的六碳阵列的容易获得的前身。
DOI: 10.1021/ol990523f
发表时间: 1999
期刊: Organic letters
影响因子: 5.2
作者: [Hentemann,M, Fuchs,PL]
通讯作者: Fuchs,PL
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG
  • 批准号:
    6456877
  • 项目类别:
  • 资助金额:
    $6.49万
  • 财政年份:
    1996
  • 负责人:
    PHILIP L FUCHS
  • 依托单位:
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG
  • 批准号:
    6370491
  • 项目类别:
  • 资助金额:
    $3.16万
  • 财政年份:
    1996
  • 负责人:
    PHILIP L FUCHS
  • 依托单位:
ONCOGENE-DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG
  • 批准号:
    2712677
  • 项目类别:
  • 资助金额:
    $20.13万
  • 财政年份:
    1996
  • 负责人:
    PHILIP L FUCHS
  • 依托单位:
ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUG
  • 批准号:
    6750698
  • 项目类别:
  • 资助金额:
    $36.84万
  • 财政年份:
    1996
  • 负责人:
    PHILIP L FUCHS
  • 依托单位:
海外基金